Barry Quart
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Heron Therapeutics, Inc. /De/ (HRTX) | Pharm.D. Former Chief Executive Officer | $736,000 | $1,145,704 |
| 2021 | Heron Therapeutics, Inc. /De/ (HRTX) | Pharm.D. Former Chief Executive Officer | $700,000 | $5,430,828 |
| 2020 | Heron Therapeutics, Inc. /De/ (HRTX) | Pharm.D. Chief Executive Officer | $676,838 | $5,346,803 |
| 2019 | Heron Therapeutics, Inc. /De/ (HRTX) | Pharm.D. Chief Executive Officer | $638,991 | $5,870,479 |
| 2018 | Heron Therapeutics, Inc. /De/ (HRTX) | Pharm.D. Chief Executive Officer | $614,414 | $5,991,297 |
| 2017 | Heron Therapeutics, Inc. /De/ (HRTX) | Pharm.D. President and Chief Executive Officer | $596,518 | $4,243,100 |
Earnings-call appearances
-
Heron Therapeutics, Inc. /De/ Q4 FY2022 Earnings Call2023-01-09
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q3 FY2022 Earnings Call2022-11-08
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q2 FY2022 Earnings Call2022-08-09
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q1 FY2022 Earnings Call2022-05-09
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q4 FY2021 Earnings Call2022-02-28
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q3 FY2021 Earnings Call2021-11-03
Heron Therapeutics, Inc. /De/ (HRTX)